This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Orchid Chemicals & Pharmaceuticals Limited. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2012
Title: Andrew Gnanaprakasam: Pioneering Innovations in Pharmaceutical Technologies
Introduction:
Andrew Gnanaprakasam, a distinguished inventor from Chennai, India, has made significant contributions to the field of pharmaceutical innovations. His relentless drive for excellence and passion for technological advancement have solidified his position as a prominent figure in the world of inventors.
Latest Patents:
Andrew Gnanaprakasam holds a total of 4 patents, with two of his latest inventions taking the spotlight:
1. "Process for the preparation of carbapenem antibiotic": This patent showcases a groundbreaking method for preparing a carbapenem antibiotic in amorphous form, revolutionizing the pharmaceutical industry.
2. "2-substituted methyl penam derivatives": A novel invention introducing 2-substituted methyl penam derivatives with a diverse range of applications in pharmaceutical compositions, further expanding the realm of possibilities in medicine.
Career Highlights:
Andrew Gnanaprakasam is a key asset at Orchid Chemicals & Pharmaceuticals Limited, where he channelizes his expertise and creativity to drive innovation within the company. His innovative mindset and problem-solving skills have significantly contributed to the success of Orchid Chemicals & Pharmaceuticals Limited in the competitive pharmaceutical market.
Collaborations:
Collaborating with esteemed professionals like Udayampalayam Palanisamy Senthilkumar and Gaddam Om Reddy, Andrew Gnanaprakasam has further enriched his research and development endeavors. Together, they have synergized their talents to create groundbreaking solutions in the pharmaceutical domain, setting new benchmarks for technological advancements.
Conclusion:
In conclusion, Andrew Gnanaprakasam's journey as an inventor exemplifies a true dedication to pushing the boundaries of innovation in pharmaceutical technologies. His remarkable contributions continue to inspire and shape the next generation of inventors, leaving an indelible mark on the landscape of technological advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile